-
1
-
-
85047696806
-
Opportunistic mycoses in the immunocompromised host: Experience at a cancer center and review
-
Anaissic, E. 1992. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin. Infect. Dis. 14:S43-S53.
-
(1992)
Clin. Infect. Dis.
, vol.14
-
-
Anaissic, E.1
-
2
-
-
17044455920
-
In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
-
Bartizal, K., C. J. Gill, G. K. Abruzzo, A. M. Flattery, L. Kong, P. M. Scott, J. G. Smith, C. E. Leighton, A. Bouffard, J. F. Dropinski, and J. Balkovec. 1997. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob. Agents Chemother. 41:2326-2332.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 2326-2332
-
-
Bartizal, K.1
Gill, C.J.2
Abruzzo, G.K.3
Flattery, A.M.4
Kong, L.5
Scott, P.M.6
Smith, J.G.7
Leighton, C.E.8
Bouffard, A.9
Dropinski, J.F.10
Balkovec, J.11
-
3
-
-
0030854825
-
In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds
-
Del Poeta, M., W. A. Schell, and J. R. Perfect. 1997. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrob. Agents Chemother. 41:1835-1836.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 1835-1836
-
-
Del Poeta, M.1
Schell, W.A.2
Perfect, J.R.3
-
4
-
-
0029983649
-
Fungal infections: A growing threat
-
Dixon, D. M., M. M. McNeil, M. L. Cohen, B. G. Gellin, and J. R. La Montagne. 1996. Fungal infections: a growing threat. Public Health Rep. 111:226-235.
-
(1996)
Public Health Rep.
, vol.111
, pp. 226-235
-
-
Dixon, D.M.1
McNeil, M.M.2
Cohen, M.L.3
Gellin, B.G.4
La Montagne, J.R.5
-
5
-
-
0031974507
-
In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens
-
Espinel-Ingroff, A. 1998. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J. Clin. Microbiol. 36:198-202.
-
(1998)
J. Clin. Microbiol.
, vol.36
, pp. 198-202
-
-
Espinel-Ingroff, A.1
-
6
-
-
0031059950
-
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
-
Espinel-Ingroff, A., M. Bartlett, R. Bowden, N. X. Chin, C. Cooper, Jr., A. Fothergill, M. R. McGinnis, P. Menezes, S. A. Messer, P. W. Nelson, F. C. Odds, L. Pasarell, J. Peter, M. A. Pfaller, J. H. Rex, M. G. Rinaldi, G. S. Shankland, T. J. Walsh, and I. Weitzman. 1997. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J. Clin. Microbiol. 35:139-143.
-
(1997)
J. Clin. Microbiol.
, vol.35
, pp. 139-143
-
-
Espinel-Ingroff, A.1
Bartlett, M.2
Bowden, R.3
Chin, N.X.4
Cooper Jr., C.5
Fothergill, A.6
McGinnis, M.R.7
Menezes, P.8
Messer, S.A.9
Nelson, P.W.10
Odds, F.C.11
Pasarell, L.12
Peter, J.13
Pfaller, M.A.14
Rex, J.H.15
Rinaldi, M.G.16
Shankland, G.S.17
Walsh, T.J.18
Weitzman, I.19
-
7
-
-
0028836230
-
Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi
-
Espinel-Ingroff, A., K. Dawson, M. Pfaller, E. Anaissie, B. Breslin, D. Dixon, A. Fothergill, V. Paetznick, J. Peter, M. Rinaldi, and T. Walsh. 1995. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrob. Agents Chemother. 39: 314-319.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 314-319
-
-
Espinel-Ingroff, A.1
Dawson, K.2
Pfaller, M.3
Anaissie, E.4
Breslin, B.5
Dixon, D.6
Fothergill, A.7
Paetznick, V.8
Peter, J.9
Rinaldi, M.10
Walsh, T.11
-
8
-
-
0026737730
-
Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality
-
Fraser, V. J., M. Jones, J. Dunkel, S. Storfer, G. Medoff, and W. C. Dunagan. 1992. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin. Infect. Dis. 15:414-421.
-
(1992)
Clin. Infect. Dis.
, vol.15
, pp. 414-421
-
-
Fraser, V.J.1
Jones, M.2
Dunkel, J.3
Storfer, S.4
Medoff, G.5
Dunagan, W.C.6
-
9
-
-
0031027261
-
In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts
-
Galgiani, J. N., and M. L. Lewis. 1997. In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts. Antimicrob. Agents Chemother. 41:180-183.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 180-183
-
-
Galgiani, J.N.1
Lewis, M.L.2
-
10
-
-
0030743451
-
Treatment of murine disseminated candidiasis with L-743,872
-
Graybill, J. R., L. K. Najvar, M. F. Luther, and A. W. Fothergill. 1997. Treatment of murine disseminated candidiasis with L-743,872. Antimicrob. Agents Chemother. 41:1775-1777.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 1775-1777
-
-
Graybill, J.R.1
Najvar, L.K.2
Luther, M.F.3
Fothergill, A.W.4
-
11
-
-
0030832091
-
Treatment of murine Candida krusei or Candida glabrata infection with L-743,872
-
Graybill, J. R., R. Bocanegra, M. Luther, A. Fothergill, and M. J. Rinaldi. 1997. Treatment of murine Candida krusei or Candida glabrata infection with L-743,872. Antimicrob. Agents Chemother. 41:1937-1939.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 1937-1939
-
-
Graybill, J.R.1
Bocanegra, R.2
Luther, M.3
Fothergill, A.4
Rinaldi, M.J.5
-
12
-
-
0029591535
-
Fungal infections in solid organ transplant recipients
-
Hadley, S., and A. W. Karchmer. 1995. Fungal infections in solid organ transplant recipients. Infect. Dis. Clin. N. Am. 9:1045-1074.
-
(1995)
Infect. Dis. Clin. N. Am.
, vol.9
, pp. 1045-1074
-
-
Hadley, S.1
Karchmer, A.W.2
-
13
-
-
0029075535
-
Epidemiology of nosocomial fungal infections, with emphasis on Candida species
-
Jarvis, W. R. 1995. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20:1526-1530.
-
(1995)
Clin. Infect. Dis.
, vol.20
, pp. 1526-1530
-
-
Jarvis, W.R.1
-
14
-
-
3543113491
-
Antifungal agents in the 1990s: Current status and future developments
-
Kauffman, C. A., and P. L. Carver. 1997. Antifungal agents in the 1990s: current status and future developments. Drugs 63:639-649.
-
(1997)
Drugs
, vol.63
, pp. 639-649
-
-
Kauffman, C.A.1
Carver, P.L.2
-
15
-
-
0028146881
-
Invasive aspergillosis in patients with AIDS
-
Khoo, S. H., and D. W. Denning. 1994. Invasive aspergillosis in patients with AIDS. Clin. Infect. Dis. 19:S41-S48.
-
(1994)
Clin. Infect. Dis.
, vol.19
-
-
Khoo, S.H.1
Denning, D.W.2
-
16
-
-
0030779919
-
Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans
-
Krishnarao, T., and J. N. Galgiani. 1997. Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans. Antimicrob. Agents Chemother. 41:1957-1960.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 1957-1960
-
-
Krishnarao, T.1
Galgiani, J.N.2
-
17
-
-
0028283764
-
Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase
-
Kurtz, M. B., I. B. Heath, J. Marrinan, S. Dreikorn, J. Onishi, and C. Douglas. 1994. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase. Antimicrob. Agents Chemother. 38:1480-1489.
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 1480-1489
-
-
Kurtz, M.B.1
Heath, I.B.2
Marrinan, J.3
Dreikorn, S.4
Onishi, J.5
Douglas, C.6
-
18
-
-
0030821205
-
Activity of SCH56592 compared with those of fluconazole and itraconazole against Candida spp
-
Law, D., C. B. Moore, and D. W. Denning. 1997. Activity of SCH56592 compared with those of fluconazole and itraconazole against Candida spp. Antimicrob. Agents Chemother. 41:2310-2311.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 2310-2311
-
-
Law, D.1
Moore, C.B.2
Denning, D.W.3
-
19
-
-
0030857403
-
Activity of the triazole SCH56592 against disseminated murine coccidioidomycosis
-
Lutz, J. E., K. V. Clemons, B. H. Aristizabal, and D. A. Stevens. 1997. Activity of the triazole SCH56592 against disseminated murine coccidioidomycosis. Antimicrob. Agents Chemother. 41:1558-1561.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 1558-1561
-
-
Lutz, J.E.1
Clemons, K.V.2
Aristizabal, B.H.3
Stevens, D.A.4
-
20
-
-
0016097131
-
Storage of stock cultures of filamentous fungi, yeasts, and some aerobic actinomycetes in sterile, distilled water
-
McGinnis, M. R. 1974. Storage of stock cultures of filamentous fungi, yeasts, and some aerobic actinomycetes in sterile, distilled water. Appl. Microbiol. 28:218-222.
-
(1974)
Appl. Microbiol.
, vol.28
, pp. 218-222
-
-
McGinnis, M.R.1
-
21
-
-
0027532280
-
The spectrum on non-Candida fungal infections following bone marrow transplantation
-
Baltimore
-
Morrison, V. A., R. J. Haake, and D. J. Weisdorf. 1993. The spectrum on non-Candida fungal infections following bone marrow transplantation. Medicine (Baltimore) 72:78-89.
-
(1993)
Medicine
, vol.72
, pp. 78-89
-
-
Morrison, V.A.1
Haake, R.J.2
Weisdorf, D.J.3
-
23
-
-
0345340404
-
The changing face of candidemia: Emergence of non Candida albicans species and antifungal resistance
-
Nguyen, M. H., J. E. Peacock, Jr., A. J. Morris, D. C. Tanner, M. L. Nguyen, D. R. Snydman, M. M. Wagener, M. G. Rinaldi, and V. L. Yu. 1996. The changing face of candidemia: emergence of non Candida albicans species and antifungal resistance. Am. J. Med. 100:617-623.
-
(1996)
Am. J. Med.
, vol.100
, pp. 617-623
-
-
Nguyen, M.H.1
Peacock Jr., J.E.2
Morris, A.J.3
Tanner, D.C.4
Nguyen, M.L.5
Snydman, D.R.6
Wagener, M.M.7
Rinaldi, M.G.8
Yu, V.L.9
-
24
-
-
0030989041
-
In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp
-
Oakley, K. L., C. B. Moore, and D. W. Denning. 1997. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp. Antimicrob. Agents Chemother. 41:1124-1126.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 1124-1126
-
-
Oakley, K.L.1
Moore, C.B.2
Denning, D.W.3
-
25
-
-
0030845020
-
Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus
-
Oakley, K. L., G. Morrissey, and D. W. Denning. 1997. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus. Antimicrob. Agents Chemother. 41:1504-1507.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 1504-1507
-
-
Oakley, K.L.1
Morrissey, G.2
Denning, D.W.3
-
26
-
-
0024994257
-
The epidemiology of pseudallescheriasis complicating transplantation: Nosocomial and community-acquired infection
-
Patterson, T. F., V. T. Andriole, M. J. Zervos, D. Therasse, and C. A. Kauffman. 1990. The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses 33:297-302.
-
(1990)
Mycoses
, vol.33
, pp. 297-302
-
-
Patterson, T.F.1
Andriole, V.T.2
Zervos, M.J.3
Therasse, D.4
Kauffman, C.A.5
-
27
-
-
0029817614
-
In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans
-
Perfect, J. R. G. M. Cox, R. K. Dodge, and W. A. Schell. 1996. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans. Antimicrob. Agents Chemother. 40:1910-1913.
-
(1996)
Antimicrob. Agents Chemother.
, vol.40
, pp. 1910-1913
-
-
Perfect, J.R.1
Cox, G.M.2
Dodge, R.K.3
Schell, W.A.4
-
28
-
-
0030896916
-
In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents
-
Pfaller, M. A., S. A. Messer, and S. Coffman. 1997. In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents. Antimicrob. Agents Chemother. 41:763-766.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 763-766
-
-
Pfaller, M.A.1
Messer, S.A.2
Coffman, S.3
-
29
-
-
0031982890
-
Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis
-
Rex, J. H., P. W. Nelson, V. L. Paetznick, M. Lozano-Chiu, A. Espinel-Ingroff, and E. J. Anaissie. 1998. Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis. Antimicrob. Agents Chemother. 42:129-134.
-
(1998)
Antimicrob. Agents Chemother.
, vol.42
, pp. 129-134
-
-
Rex, J.H.1
Nelson, P.W.2
Paetznick, V.L.3
Lozano-Chiu, M.4
Espinel-Ingroff, A.5
Anaissie, E.J.6
-
30
-
-
0030970811
-
In vitro activity of a new echinocandin. LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates
-
Uzun, O., S. Kocagöz, Y. Çetinkaya, S. Arikan, and S. Ünal. 1997. In vitro activity of a new echinocandin. LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates. Antimicrob. Agents Chemother. 41:1156-1157.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 1156-1157
-
-
Uzun, O.1
Kocagöz, S.2
Çetinkaya, Y.3
Arikan, S.4
Ünal, S.5
-
31
-
-
0030757452
-
In vitro activity of a new pneumocandin antifungal, L-743,872. against azole-susceptible and -resistant Candida species
-
Vazquez, J. A., M. Lynch, D. Boikov, and J. Sobel. 1997. In vitro activity of a new pneumocandin antifungal, L-743,872. against azole-susceptible and -resistant Candida species. Antimicrob. Agents Chemother. 41:1612-1614.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 1612-1614
-
-
Vazquez, J.A.1
Lynch, M.2
Boikov, D.3
Sobel, J.4
-
32
-
-
0028922813
-
Fungemia in children infected with the human immunodeficiency virus: New epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy
-
Walsh, T. J., C. Gonzalez, E. Roilides, B. U. Mueller, N. Ali, L. L. Lewis, T. O. Whitcomb, D. J. Marshall, and P. A. Pizzo. 1995. Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy. Clin. Infect. Dis. 20:900-906.
-
(1995)
Clin. Infect. Dis.
, vol.20
, pp. 900-906
-
-
Walsh, T.J.1
Gonzalez, C.2
Roilides, E.3
Mueller, B.U.4
Ali, N.5
Lewis, L.L.6
Whitcomb, T.O.7
Marshall, D.J.8
Pizzo, P.A.9
-
33
-
-
0030896919
-
In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species
-
Zhanel, G. G., J. A. Karlowsky, G. A. J. Harding, T. V. Balko, S. A. Zelenitsky, M. Friesen, A. Kabani, M. Turik, and D. J. Hoban. 1997. In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species. Antimicrob. Agents Chemother. 41:863-865.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 863-865
-
-
Zhanel, G.G.1
Karlowsky, J.A.2
Harding, G.A.J.3
Balko, T.V.4
Zelenitsky, S.A.5
Friesen, M.6
Kabani, A.7
Turik, M.8
Hoban, D.J.9
|